|
May 15
|
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
|
|
May 15
|
Jennifer Schneider Elected to Vertex Board of Directors
|
|
May 14
|
Vertex Stock Hit All-Time High, Paused, Rising Again
|
|
May 14
|
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
|
|
May 12
|
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
|
|
May 12
|
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
|
|
May 10
|
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
|
|
May 9
|
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
|
|
May 9
|
Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
|
|
May 9
|
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
|
|
May 9
|
Decoding Vertex Pharmaceuticals Inc (VRTX): A Strategic SWOT Insight
|
|
May 7
|
Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript
|
|
May 6
|
UPDATE 1-Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
|
|
May 6
|
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
|
|
May 6
|
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
|
|
May 6
|
Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
|
|
May 6
|
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
|
|
May 6
|
Vertex Reports First Quarter 2024 Financial Results
|
|
May 6
|
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
|
|
May 5
|
3 No-Brainer Stocks to Buy in May
|